AT331425B - Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen - Google Patents

Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen

Info

Publication number
AT331425B
AT331425B AT643473A AT643473A AT331425B AT 331425 B AT331425 B AT 331425B AT 643473 A AT643473 A AT 643473A AT 643473 A AT643473 A AT 643473A AT 331425 B AT331425 B AT 331425B
Authority
AT
Austria
Prior art keywords
methylergolines
subst
halogen
methyl
new
Prior art date
Application number
AT643473A
Other languages
German (de)
English (en)
Other versions
ATA643473A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to AT143675A priority Critical patent/AT332568B/de
Priority to AT143575A priority patent/AT333985B/de
Publication of ATA643473A publication Critical patent/ATA643473A/de
Application granted granted Critical
Publication of AT331425B publication Critical patent/AT331425B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT643473A 1972-07-21 1973-07-20 Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen AT331425B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT143675A AT332568B (de) 1972-07-21 1975-02-25 Verfahren zur herstellung eines neuen d-2,6-dimethyl-8-cyano-(carboxamido)-methylergolins und von dessen salzen
AT143575A AT333985B (de) 1972-07-21 1975-02-25 Verfahren zur herstellung von neuen d-2-subst.-6-methyl-8-cyanomethylergolinen und deren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27390272A 1972-07-21 1972-07-21

Publications (2)

Publication Number Publication Date
ATA643473A ATA643473A (de) 1975-11-15
AT331425B true AT331425B (de) 1976-08-25

Family

ID=23045910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT643473A AT331425B (de) 1972-07-21 1973-07-20 Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen

Country Status (24)

Country Link
JP (2) JPS576431B2 (US08124317-20120228-C00026.png)
AR (3) AR206772A1 (US08124317-20120228-C00026.png)
AT (1) AT331425B (US08124317-20120228-C00026.png)
BE (1) BE802531A (US08124317-20120228-C00026.png)
BG (3) BG21410A3 (US08124317-20120228-C00026.png)
CA (1) CA1006159A (US08124317-20120228-C00026.png)
CH (5) CH578564A5 (US08124317-20120228-C00026.png)
CS (1) CS208164B2 (US08124317-20120228-C00026.png)
DD (1) DD107690A5 (US08124317-20120228-C00026.png)
DE (2) DE2365974A1 (US08124317-20120228-C00026.png)
DK (1) DK140986B (US08124317-20120228-C00026.png)
ES (5) ES417078A1 (US08124317-20120228-C00026.png)
FR (1) FR2193606B1 (US08124317-20120228-C00026.png)
GB (1) GB1423065A (US08124317-20120228-C00026.png)
HU (1) HU167274B (US08124317-20120228-C00026.png)
IE (1) IE37936B1 (US08124317-20120228-C00026.png)
IL (3) IL42730A (US08124317-20120228-C00026.png)
NL (1) NL7309969A (US08124317-20120228-C00026.png)
PH (1) PH11229A (US08124317-20120228-C00026.png)
RO (2) RO63792A (US08124317-20120228-C00026.png)
SE (3) SE393111B (US08124317-20120228-C00026.png)
SU (3) SU645581A3 (US08124317-20120228-C00026.png)
YU (1) YU36953B (US08124317-20120228-C00026.png)
ZA (1) ZA734627B (US08124317-20120228-C00026.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
JPH0596382U (ja) * 1992-05-28 1993-12-27 イビデン株式会社 ドアユニット

Also Published As

Publication number Publication date
JPS4985099A (US08124317-20120228-C00026.png) 1974-08-15
IE37936L (en) 1974-01-21
FR2193606A1 (US08124317-20120228-C00026.png) 1974-02-22
FR2193606B1 (US08124317-20120228-C00026.png) 1977-07-15
IL48288A (en) 1976-06-30
AU5792673A (en) 1975-01-16
SU645581A3 (ru) 1979-01-30
IE37936B1 (en) 1977-11-23
CH580626A5 (US08124317-20120228-C00026.png) 1976-10-15
RO71305A (ro) 1982-03-24
DE2335750B2 (de) 1978-02-23
SU584780A3 (ru) 1977-12-15
NL7309969A (US08124317-20120228-C00026.png) 1974-01-23
YU36953B (en) 1984-08-31
ES442885A1 (es) 1977-04-16
CH578564A5 (US08124317-20120228-C00026.png) 1976-08-13
DE2335750A1 (de) 1974-02-14
SE7611467L (sv) 1976-10-15
DK140986B (da) 1979-12-17
GB1423065A (en) 1976-01-28
ES446789A1 (es) 1977-06-01
ZA734627B (en) 1974-06-26
AR206772A1 (es) 1976-08-23
DD107690A5 (US08124317-20120228-C00026.png) 1974-08-12
YU194573A (en) 1982-06-18
DE2365974A1 (de) 1977-03-24
JPS5813541B2 (ja) 1983-03-14
SE393111B (sv) 1977-05-02
DK140986C (US08124317-20120228-C00026.png) 1980-07-21
BG21410A3 (US08124317-20120228-C00026.png) 1976-05-20
AR210072A1 (es) 1977-06-30
JPS5781487A (en) 1982-05-21
BG21411A3 (US08124317-20120228-C00026.png) 1976-05-20
CS208164B2 (en) 1981-08-31
AR206887A1 (es) 1976-08-31
RO63792A (fr) 1978-12-15
CA1006159A (en) 1977-03-01
BE802531A (fr) 1974-01-21
SE410459B (sv) 1979-10-15
ES417078A1 (es) 1976-05-01
JPS576431B2 (US08124317-20120228-C00026.png) 1982-02-04
IL42730A (en) 1976-06-30
ES442887A1 (es) 1977-05-16
DE2335750C3 (de) 1978-10-19
CH581135A5 (US08124317-20120228-C00026.png) 1976-10-29
SU575029A3 (ru) 1977-09-30
SE7611466L (sv) 1976-10-15
HU167274B (US08124317-20120228-C00026.png) 1975-09-27
CH578563A5 (US08124317-20120228-C00026.png) 1976-08-13
ATA643473A (de) 1975-11-15
ES442886A1 (es) 1977-04-16
SE410603B (sv) 1979-10-22
IL48288A0 (en) 1975-12-31
IL42730A0 (en) 1973-10-25
PH11229A (en) 1977-10-28
BG22400A3 (US08124317-20120228-C00026.png) 1977-02-20
CH580625A5 (US08124317-20120228-C00026.png) 1976-10-15

Similar Documents

Publication Publication Date Title
AT325206B (de) Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen
ATA569473A (de) Verfahren zur herstellung von neuen enolderivaten
AT329068B (de) Verfahren zur herstellung von neuen chinoxalin-di -n- oxid-derivaten
AT335418B (de) Verfahren zur herstellung von neuen alkylthiocyclopentanderivaten
AT327194B (de) Verfahren zur herstellung von neuen 2-alkylamino-dihydropyridinen
AT327942B (de) Verfahren zur herstellung von neuen n-phenyl-carbaminsaure- beta -phenoxyathylestern
ATA940173A (de) Verfahren zur herstellung von neuen farbstoffen
AT331425B (de) Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen
AT325764B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinen
AT332395B (de) Verfahren zur herstellung von neuen fluor-substituierten thioxanthenen
AT323148B (de) Verfahren zur herstellung von neuen 5-aroylfuranderivaten
ATA593373A (de) Verfahren zur herstellung von neuen dihydrodigoxin-derivaten
AT330964B (de) Verfahren zur herstellung von neuen cardenolid-3- (2'-desoxy-glykosiden)
AT345272B (de) Verfahren zur herstellung von aminoanthrachinonen
AT326097B (de) Verfahren zur herstellung von 3-fluor-d-alanin
AT324328B (de) Verfahren zur herstellung von neuen tetrahydropyran- bzw. -thiopyranderivaten
AT326096B (de) Verfahren zur herstellung von 3-fluor-d-alanin
AT325786B (de) Verfahren zur herstellung von eburnamoninen
AT327160B (de) Verfahren zur herstellung von alkylen-bis-amiden
AT324294B (de) Verfahren zur herstellung von 3-fluor-d-alanin
AT332542B (de) Verfahren zur herstellung von neuen 7-acylamido -1-x-1- dethiacephalosporinderivaten
AT331971B (de) Verfahren zur herstellung von neuen 3-monoestern von rosamicin
AT327169B (de) Verfahren zur herstellung von neuen n-(4-fluoranilinocarbonylmethyl)-n-alkyl-dimethylammoniumverbindungen
AT330369B (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- amino-propanen
ATA137175A (de) Verfahren zur herstellung von neuen aminophenyl-athanolaminen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee